News Tag: COVID-19
-
Scripps Research awarded $67 million by NIH to lead new pandemic preparedness center
The multidisciplinary center will focus on development of antiviral drugs to combat coronaviruses and other viruses with pandemic potential.
-
Scripps Research scientists explain what makes COVID-19 antibody “J08” so potent
The antibody, already in clinical trials to treat COVID-19, may be effective against future variants.
-
Smartwatches and fitness bands reveal individual physiological responses to COVID-19 vaccine
Scripps Research scientists find digital biomarkers that could be associated with vaccine-induced immune response.
-
AbbVie and Scripps Research announce collaboration to develop antiviral treatments for COVID-19
Global collaboration seeks to develop potential novel, direct-acting antiviral treatments for COVID-19.
-
Scripps Research discovery could enable broad coronavirus vaccine
Scientists identified vulnerable site on multiple coronaviruses that could be targeted to prevent future pandemics.
-
New electron microscopy technique could shortcut the development of vaccines and monoclonal antibody therapies
The new method by scientists at Scripps Research identifies specific antibodies in immune responses to vaccination or infection in fraction of time needed for traditional approach.
-
New SARS-CoV-2 vaccine candidate shows great promise against variants of concern
Study suggests the experimental vaccine may engage the immune system much more robustly than other vaccine strategies.
-
Computational biologists aim to solve science’s ‘scattered data’ problem with $7.5 million contract
Data ecosystem to be built for National Institute of Allergy and Infectious Diseases will give researchers a secure way to collaborate on research and medical advances.
-
Potential drug against COVID-19 found among tapeworm medications
A new molecule hinders COVID-19 viral replication and related inflammation in rodent studies.
-
Mardi Gras 2020: A Fateful Super-Spreader Event
New Orleans’ Mardi Gras festival of February 2020 appears to have driven one of the worst early outbreaks of COVID-19 in the United States, according to a study led by scientists at Scripps Research.